ACELYRIN INC. - COMMON STOCK

ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

27 11 2023 16:30:00 提供 Nasdaq GlobeNewswire

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

07 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer

06 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023

31 10 2023 16:30:00 提供 Nasdaq GlobeNewswire

ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development

03 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa

11 9 2023 16:05:00 提供 Nasdaq GlobeNewswire